BOCOUTURE® 100 Units (Xeomin)

$359.00

Brand: BOCOUTURE®
Manufacturer: Merz Pharmaceuticals GmbH
Active Substances: Botulinum toxin type A (150 kDa), free from complexing proteins
Strength: 100 Units per vial
Pack Size: 1 vial

Quantity Discount (%) Price
1 - 5 $359.00
6 - 10 2.79 % $349.00
11 - 20 4.18 % $344.00
21+ 5.57 % $339.00
SKU: sku_1488312452_1 Category: Tag:

Additional information

BOCOUTURE 100 Units is a highly purified botulinum toxin type A formulation specifically engineered without complexing proteins. This innovative product ensures reduced risks of immunogenic responses, making it suitable for repeat treatments. BOCOUTURE is primarily indicated for the temporary reduction of moderate to severe glabellar lines in adults but can also be used therapeutically for muscle hyperactivity conditions. Its reliable efficacy and safety profile make it a preferred choice for both healthcare professionals and patients.

Main Treatment Areas

  • Aesthetic Uses:
    • Reduction of moderate to severe glabellar lines (frown lines).
    • Treatment of forehead lines and crow’s feet.
    • Facial contouring for specific areas, such as the jawline.
  • Therapeutic Applications:
    • Management of cervical dystonia.
    • Treatment of spasticity and muscle hyperactivity.
    • Relief of excessive sweating (hyperhidrosis) in the axillary area.

Key Benefits

  • Purity: BOCOUTURE is free from complexing proteins, reducing the risk of immune reactions and making it ideal for long-term usage.
  • Consistency: Provides reliable results for both therapeutic and aesthetic purposes, with a strong safety profile.
  • Precision: Its refined formulation allows for highly targeted applications, ensuring effectiveness in small doses.
  • Flexibility: Versatile use in both cosmetic and medical treatments, offering tailored solutions for patients’ unique needs.

Safety Information

BOCOUTURE 100 Units should be administered only by trained healthcare professionals. Side effects may include localized pain, redness, or swelling at the injection site, as well as potential temporary muscle weakness. It is contraindicated in patients with known hypersensitivity to botulinum toxin type A or any excipients, and those with active infections in the injection area. Pregnant or breastfeeding patients should consult their physician before use. Regular monitoring and adherence to the recommended dosage are essential to minimize risks.

 BOCOUTURE 100 Units (Xeomin) Pricing Information

For clinics and healthcare professionals seeking BOCOUTURE 100U (Xeomin), Dr Sales Direct is a trusted wholesale supplier offering competitive wholesale prices. To access specific pricing details and complete your purchase, please visit Dr Sales Direct and sign in to view detailed wholesale rates. Dr Sales Direct ensures cost-effective solutions for aesthetic practices, providing high-quality products at the best prices.

Frequently Asked Questions

BOCOUTURE® 100 Units (Xeomin) and BOTOX® COSMETIC 100 Units are both botulinum toxin type A products used for medical and aesthetic purposes, but they have several key differences in formulation, composition, and handling.

  1. Formulation and Composition:
    • BOCOUTURE® (Xeomin): Manufactured by Merz Pharmaceuticals, BOCOUTURE® is a “naked” botulinum toxin type A, meaning it is free from complexing proteins. This high purity reduces the risk of developing neutralizing antibodies, which could make the treatment less effective over time.
    • BOTOX® COSMETIC: Produced by Allergan, BOTOX® COSMETIC includes accessory proteins in its formulation. These proteins, while not active in treatment, can potentially contribute to immunogenicity in certain patients.
  2. Stability and Storage:
    • BOCOUTURE®: Does not require refrigeration before reconstitution, which makes it easier to store and handle, especially in clinic settings.
    • BOTOX® COSMETIC: Requires refrigeration before reconstitution to maintain its stability, making storage conditions more stringent.
  3. Use Cases:
    • Both products are used for aesthetic treatments, such as smoothing dynamic wrinkles (e.g., glabellar lines, crow’s feet, and forehead lines), as well as therapeutic conditions like spasticity and hyperhidrosis. However, individual approvals and guidelines for specific indications may vary slightly depending on regulatory authorities.
  4. Duration of Effect:
    • Clinical studies have shown that the duration of effect for both BOCOUTURE® and BOTOX® COSMETIC is similar, typically lasting 3-6 months. However, patient-specific factors may influence efficacy and longevity.
  5. Immunogenicity Risk:
    • BOCOUTURE®: The absence of complexing proteins lowers the risk of immunogenicity, which means that patients are less likely to develop resistance over repeated treatments.
    • BOTOX® COSMETIC: Contains complexing proteins, which may slightly increase the risk of antibody formation in some individuals over time.
  6. Cost:
    • The cost of the two products varies by supplier, region, and market conditions. Generally, both are premium products, but pricing dynamics may favor one over the other depending on clinic contracts and wholesale suppliers.

Conclusion: The choice between BOCOUTURE® and BOTOX® COSMETIC depends on clinical goals, patient-specific needs, and physician preference. BOCOUTURE® is often favored for its pure formulation and ease of handling, while BOTOX® COSMETIC benefits from brand recognition and extensive clinical history.